The lancet oncology
-
The lancet oncology · Mar 2022
Retraction Of PublicationRetraction and republication-Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.